James L. Fox, Jr., MD, is the founding leader of the Ravine Way Surgery Center in Glenview, Ill., and practices at the Illinois Bone & Joint Institute. He is a board-certified orthopedic surgeon who has been practicing for more than…
The Latest
Daniel Daube, Jr., MD, is the founder of Surgical Center for Excellence in Panama City, Fla., and a plastic surgeon with Gulf Coast Facial Plastics & ENT Center.
The Joint Commission has released an R3 Report that provides detailed information about a requirement that all Joint Commission-accredited healthcare organizations establish an annual influenza vaccination program for licensed independent practitioners and staff.
The question in today's healthcare market should not be, "Should we offer incentive bonuses?" says Greg Zoch, managing director and partner with Kaye-Bassman. He says while the baby boomer generation generally doesn't count on bonuses as part of their compensation,…
Scott Shiflett, a patient from Anniston, Ala., recently wrote to the Anniston Star to praise his recent procedure at the Surgery Center of Oxford.
Representatives from the American Medical Association and Medical Group Management Association sent letters to House Ways and Means Committee chairs Dave Camp (R-Mich.) and Wally Herger (R-Calif.) to suggest alternatives to the current Medicare sustainable growth rate, according to a…
The Budget Control Act that Congress passed in late August capped reductions in Medicare spending at no more than 2 percent each year, which could produce total savings of $123 billion over 10 years, according to an ASC Association report.
The average national hiring bonus for registered nurses was $3,000 over the past 12 months, and hospitals and health systems in general have provided a 2.3 percent average merit and market increase to staff-level nurses, according to Integrated Healthcare Strategies'…
A new study found that a physician's specialty affects the outcome of medical malpractice lawsuits, according to an American Medical News report.
Endo Health Solutions this week announced that Watson Pharmaceuticals will be able to market its generic version of the pain medication Lidoderm beginning in 2013, according to an Investor's Business Daily report.